A substantial number of medications have been described to prolong the QT interval, which can predispose patients to potentially fatal ventricular arrhythmias. When patients are prescribed medications known to prolong the QT interval, a 12-lead ECG is often ordered at baseline and at regular intervals to monitor for QT prolongation.  The resultant patient charge per 12-lead ECG for recording and interpretation by a cardiologist is approximately $500.  To avoid the cost of baseline and serial ECG monitoring, a patient’s QTc can be monitored and recorded electronically from the central telemetry monitor at no direct cost.  This proposal can be implemented by addition of a documentation flowsheet row and nursing order for QTc monitoring via telemetry in APeX.  The charted QT interval can be displayed on the APeX Comprehensive Flowsheet viewable adjacent to the patient’s vital signs and cardiac medications.  In summary, it will allow for cost-effective monitoring and electronic documentation of the patient’s QT interval in a manner that is available in real time to all members of the healthcare team.